# Pharmaloz Manufacturing to increase plant capacity by over 50%

Pharmaloz Manufacturing, a subsidiary of ProPhase Labs, is expanding its plant capacity by over 50% through automation equipment and efficiencies, raising annual production capability from below $10 million to over $15 million.

- Type: Expansion
- Announced: 2024-01-23
- Where: United States
- Status: announced
- Capacity: over 50% increase, annual production capability from below $10 million to over $15 million
- Products: lozenges, blister packing
- Sectors: [Packaging](https://endata.com/sectors/packaging.md)

## Companies

- [Pharmaloz Manufacturing](https://endata.com/companies/75193.md)
- [ProPhase Labs](https://endata.com/companies/75194.md) (partner)

## Sources

- [biospace.com](https://www.biospace.com/pharmaloz-manufacturing-accelerates-expansion-improves-pricing-boosts-profitability-and-secures-new-contracts), 2024-01-23: "PMI recently acquired cutting-edge automation equipment and, with other operating efficiencies, is set to escalate plant capacity by over 50%"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.